EUVIMEDEUVIMED entdecken
Kohortenstudie

Polycystic ovary syndrome in relation to musculoskeletal health outcomes during midlife: a longitudinal cohort study

Maryam Kazemi, Sheryl L Rifas-Shiman, Elaine W Yu, Siwen Wang, Marie-France Hivert, Wei Perng, Victoria Fitz, Jan Shifren, Emily Oken, Jorge E Chavarro

Reproductive BioMedicine Online · 2025

DOI: 10.1016/j.rbmo.2025.105068 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Reproductive BioMedicine Online, 2025. Verfasst von Maryam Kazemi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.. Electronic address: mkazemi@hsph.harvard.edu. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: NICHD NIH HHS, NIEHS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: Is polycystic ovary syndrome (PCOS) associated with adverse musculoskeletal outcomes during the menopausal transition? DESIGN: Parous women (n = 409) were enrolled from Project Viva, a prospective cohort study, and followed for 17 years. Women were classified as 'diagnosed PCOS' (n = 26) 3 years after enrolment; 'probable PCOS' (n = 41), based on the presence of two or more PCOS traits; and 'no PCOS' (n = 342). Musculoskeletal health outcomes were assessed by dual-energy X-ray absorptiometry, procollagen type I N-propeptide (P1NP) and C-terminal telopeptide of type I collagen [CTX-1] at a hospital visit at 17 years. Associations were evaluated using linear regressions. RESULTS: At the mid-life visit, mean (SD) age was 51 (5) years, and 177 out of 409 (43%) women had reached menopause. Diagnosed and probable PCOS was associated with higher BMD at spine (0.05 [0.01, 0.09] g/cm2) and hip (0.05 [0.01, 0.08] g/cm2) but with lower CTX-1 (-13.7 [-23.7, -2.5] %) in age-adjusted analyses. After midlife whole-body fat mass adjustment, PCOS remained associated with spine (0.04 [0.00, 0.08] g/cm2) and hip BMD (0.04 [0.01, 0.07] g/cm2) and CTX-1 (-13.0 [-23.0, -1.8] %). Models adjusting for BMI versus fat mass showed similar results, although some confidence intervals included null values. When stratified by midlife menopausal status, PCOS was associated with spine (0.09 [0.02, 0.16] g/cm2) and hip (0.07 [0.02, 0.13] g/cm2) BMD only among post-menopausal women. CONCLUSIONS: PCOS is positively correlated to BMD (spine, hip) and inversely associated with bone turnover (CTX-1) in mid-life, independent of body fat, particularly after the menopause.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeHumansFemaleLongitudinal StudiesMiddle AgedBone DensityProspective StudiesAbsorptiometry, PhotonAdultMenopauseCollagen Type IProcollagenPeptide Fragments

Stichwörter der Autor:innen

body compositionbonemetabolismpolycystic ovary syndromeskeletal muscle

Substanzen

Collagen Type IProcollagenPeptide Fragments

Autor:innen und Institutionen

  • Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.. Electronic address: mkazemi@hsph.harvard.edu.
  • Division of Chronic Disease Research across the Lifecourse (CoRAL), Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA.
  • Endocrine Unit, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.
  • Division of Chronic Disease Research across the Lifecourse (CoRAL), Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA.; Diabetes Unit, Massachuset…
  • Department of Epidemiology, Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Förderung

  • NICHD NIH HHS
  • NIEHS NIH HHS
  • NIA NIH HHS
  • National Institute on Aging
  • Office of Research on Women's Health
  • National Institutes of Health

Zitieren

APA

Kazemi, M., Rifas-Shiman, S. L., Yu, E. W., Wang, S., Hivert, M. F., Perng, W., Fitz, V., Shifren, J., Oken, E., & Chavarro, J. E. (2025). Polycystic ovary syndrome in relation to musculoskeletal health outcomes during midlife: a longitudinal cohort study. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2025.105068

Vancouver

Kazemi M, Rifas-Shiman SL, Yu EW, Wang S, Hivert MF, Perng W, et al. Polycystic ovary syndrome in relation to musculoskeletal health outcomes during midlife: a longitudinal cohort study. Reproductive BioMedicine Online. 2025. doi:10.1016/j.rbmo.2025.105068

BibTeX
@article{Kazemi2025,
  author = {Kazemi, Maryam and Rifas-Shiman, Sheryl L and Yu, Elaine W and Wang, Siwen and Hivert, Marie-France and Perng, Wei and Fitz, Victoria and Shifren, Jan and Oken, Emily and Chavarro, Jorge E},
  title = {Polycystic ovary syndrome in relation to musculoskeletal health outcomes during midlife: a longitudinal cohort study},
  journal = {Reproductive BioMedicine Online},
  year = {2025},
  doi = {10.1016/j.rbmo.2025.105068}
}
Kostenlos starten →